Reuters logo
BRIEF-Aduro Biotech announces FDA clearance of investigational new drug application
June 1, 2017 / 12:20 PM / 7 months ago

BRIEF-Aduro Biotech announces FDA clearance of investigational new drug application

June 1 (Reuters) - Aduro Biotech Inc:

* Aduro Biotech announces FDA clearance of investigational new drug application to evaluate the combination of ADU-s100 with pdr001 for the treatment of solid tumors and lymphomas

* Aduro Biotech Inc - phase 1b study is expected to be initiated in second half of 2017

* Aduro Biotech says it will continue to evaluate potential of adu-s100 as a monotherapy in cutaneously accessible tumors as well as viscerally accessible tumors Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below